| ICD-10-CM-2023 > E00-E89 > E20-E35 > E25 |
E20-E35 | Disorders of other endocrine glands | |
Excl1.: | galactorrhea (N64.3) gynecomastia (N62) | |
E25 | Adrenogenital disorders | |
Incl.: | adrenogenital syndromes, virilizing or feminizing, whether acquired or due to adrenal hyperplasia consequent on inborn enzyme defects in hormone synthesis Female adrenal pseudohermaphroditism Female heterosexual precocious pseudopuberty Male isosexual precocious pseudopuberty Male macrogenitosomia praecox Male sexual precocity with adrenal hyperplasia Male virilization (female) | |
Excl1.: | indeterminate sex and pseudohermaphroditism (Q56) chromosomal abnormalities (Q90-Q99) | |
E25.0 | Congenital adrenogenital disorders associated with enzyme deficiency | |
Info: | Congenital adrenal hyperplasia 21-Hydroxylase deficiency Salt-losing congenital adrenal hyperplasia | |
E25.8 | Other adrenogenital disorders | |
Info: | Idiopathic adrenogenital disorder | |
Use add'l | code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) | |
E25.9 | Adrenogenital disorder, unspecified | |
Info: | Adrenogenital syndrome NOS | |
|
ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine |